Talk:Karen Ashe

Latest comment: 1 year ago by SandyGeorgia in topic Undue content in the lead

Cats edit

Myxomatosis57 would not a change of this nature require that the allegations are substantiated? Particularly for a WP:BLP? All investigators (NIH, UMN and Nature) are still out. SandyGeorgia (Talk) 16:16, 26 July 2022 (UTC)Reply

Cleaning up recent edits edit

Regarding this edit:

  • Independent, third-party sourcing is required for claims of this nature (that is, they cannot be cited to Ashe herself): [1]
  • the first mutation linked to a neurodegenerative disease, which has been cited more than 1,000 times. Please see WP:OR; we can't do our own research, rather need secondary sources to cover the number of times cited.
  • Please see WP:CQ, MOS:LQ, MOS:DASH, MOS:PEOPLETITLES and MOS:JOBTITLES.
  • Well cited text was removed, and replaced by original research; in this edit, I restored the cited text, and removed the OR has been cited more than 5,000 times and most cited and influential paper Ashe has published. If there is a secondary source (that is, not related to Ashe or UMN) that states this, please provide it.
  • Unexplained removal of well-cited text:
    • Ashe is the founding director of the UMN's N. Bud Grossman Center for Memory Research and Care.[1][2]

References

  1. ^ "Team". N. Bud Grossman Center for Memory Research and Care: University of Minnesota. Archived from the original on July 12, 2017. Retrieved July 30, 2022.
  2. ^ "Not giving up". University of Minnesota Foundation. Archived from the original on July 12, 2017. Retrieved August 1, 2022.
  • Please see WP:OR (and another unexplained removal of well-cited text). The paper has been cited over 3,000 times is WP:OR; we have reliable sources describing the importance of the paper and don't need to do our own research. This entire passage is original research (as well as unnecessary WP:PUFFERY; again, we have sources already describing the importance of the paper):

    suggesting that it could play a role in the silent, prodromal phase of Alzheimer's disease. Aβ*56 is unrelated to amyloid plaques, the structures against which most current Alzheimer’s antibody therapies are directed. The paper is significant because it suggests that some forms of Aβ may contribute to the development of memory deficits independent of amyloid plaques.

    I have restored the cited text in this edit.
  • All of this is synthesis.
  • More of similar here; the clause beginning with The allegations of the report were problematic because is original research, and have restored cited text which was removed. Wikipedia does not publishe original research.
  • Why is the 2015 "Quaternary structure defines a large class of amyloid-beta oligomers neutralized by sequestration" singled out in the text; what secondary sources have covered it?

SandyGeorgia (Talk) 02:22, 25 August 2022 (UTC)Reply

Undue content in the lead edit

An IP is adding WP:UNDUE content to the lead, [2] [3] and doing so in a way that breaks citation integrity and introduces terms in the lead that are not defined (Lesne and the 2006 publication). The primary allegations are not against Ashe, although she is a coauthor on the paper with her fellow Sylvain Lesné. If this content is worthy of mention in the lead (I'm not sure it is), the lead needs to be better balanced (this is one small part of an overall successful career), and it needs to be added correctly (with defined terms and without breaking citations). SandyGeorgia (Talk) 18:54, 24 December 2022 (UTC)Reply